secwatch.observer — SEC 8-K summary
======================================

Issuer:     IO Biotech, Inc. (IOBTQ)
CIK:        0001865494
Form:       8-K
Filed at:   2022-05-26T23:59:59+00:00
Accession:  0001193125-22-160961
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

IO Biotech stockholders elect Nielsen and Smith as Class I directors, ratify EY as auditor
--------------------------------------------------------------------------------

- Jack B. Nielsen elected with 22,460,202 for, 938,718 withheld, 320,057 broker non-votes.
- David V. Smith elected with 23,387,185 for, 11,735 withheld, 320,057 broker non-votes.
- Ratification of EY as independent auditor for FY2022: 23,707,581 for, 10,261 against, 1,136 abstain, no broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1865494/000119312522160961/0001193125-22-160961-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1865494/000119312522160961/d364496d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-160961

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer